Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Short-Term Debt issuances (2016 - 2023)

China Pharma Holdings (CPHI) has disclosed Short-Term Debt issuances for 4 consecutive years, with $1.0 million as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Short-Term Debt issuances changed N/A year-over-year to $1.0 million, compared with a TTM value of $1.0 million through Dec 2024, down 32.96%, and an annual FY2024 reading of $492761.0, down 67.85% over the prior year.
  • Short-Term Debt issuances was $1.0 million for Q4 2023 at China Pharma Holdings, up from -$6171.0 in the prior quarter.
  • Across five years, Short-Term Debt issuances topped out at $3.0 million in Q3 2021 and bottomed at -$6171.0 in Q3 2023.
  • Average Short-Term Debt issuances over 3 years is $690606.6, with a median of $336052.0 recorded in 2020.
  • Peak annual rise in Short-Term Debt issuances hit 292.66% in 2021, while the deepest fall reached 92.68% in 2021.
  • Year by year, Short-Term Debt issuances stood at $160979.0 in 2020, then plummeted by 92.68% to $11790.0 in 2021, then soared by 8667.42% to $1.0 million in 2023.
  • Business Quant data shows Short-Term Debt issuances for CPHI at $1.0 million in Q4 2023, -$6171.0 in Q3 2023, and -$6011.0 in Q2 2023.